vs
Steris（STE）とVontier Corp（VNT）の財務データ比較。上の社名をクリックして会社を切り替えられます
Sterisの直近四半期売上が大きい（$1.5B vs $808.5M、Vontier Corpの約1.9倍）。Vontier Corpの純利益率が高く（15.3% vs 12.9%、差は2.4%）。Sterisの前年同期比売上増加率が高い（9.2% vs 4.1%）。Sterisの直近四半期フリーキャッシュフローが多い（$199.5M vs $174.8M）。過去8四半期でSterisの売上複合成長率が高い（15.8% vs 3.4%）
Steris plcは米国とアイルランドを拠点とする医療機器メーカーで、米国の医療システム向けに滅菌サービスや手術関連製品を専門に提供している。実質的な運営本部はオハイオ州メンターにあり、医療現場の感染対策や手術支援のための高品質なソリューションを展開している。
Vontierコーポレーションは米国ノースカロライナ州ローリーに本社を置く産業製造企業で、Gilbarco Veeder-Root、Matco Tools、Teletrac Navmanといったブランドを所有し、子会社にHennessy Industries、Gasboy、Global Traffic Technologies（GTT）などがあります。
STE vs VNT — 直接比較
売上が大きい
STE
1.9倍大きい
$808.5M
売上成長率が高い
STE
+5.1%の差
4.1%
純利益率が高い
VNT
純利益率が2.4%高い
12.9%
フリーキャッシュフローが多い
STE
FCF $24.7M多い
$174.8M
2年売上CAGRが高い
STE
2年複合成長率
3.4%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $808.5M |
| 純利益 | $192.9M | $123.5M |
| 粗利率 | 43.8% | — |
| 営業利益率 | 18.3% | 18.9% |
| 純利益率 | 12.9% | 15.3% |
| 売上前年比 | 9.2% | 4.1% |
| 純利益前年比 | 11.2% | 0.0% |
| EPS（希薄化後） | $1.96 | $0.85 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上STEVNT
| Q4 25 | $1.5B | $808.5M | ||
| Q3 25 | $1.5B | $752.5M | ||
| Q2 25 | $1.4B | $773.5M | ||
| Q1 25 | $1.5B | $741.1M | ||
| Q4 24 | $1.4B | $776.8M | ||
| Q3 24 | $1.3B | $750.0M | ||
| Q2 24 | $1.3B | $696.4M | ||
| Q1 24 | $1.1B | $755.8M |
純利益STEVNT
| Q4 25 | $192.9M | $123.5M | ||
| Q3 25 | $191.9M | $102.8M | ||
| Q2 25 | $177.4M | $91.9M | ||
| Q1 25 | $145.7M | $87.9M | ||
| Q4 24 | $173.5M | $123.5M | ||
| Q3 24 | $150.0M | $91.8M | ||
| Q2 24 | $145.4M | $70.1M | ||
| Q1 24 | $-1.4M | $136.8M |
粗利率STEVNT
| Q4 25 | 43.8% | — | ||
| Q3 25 | 44.2% | 47.3% | ||
| Q2 25 | 45.1% | 47.9% | ||
| Q1 25 | 43.3% | 47.3% | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 43.6% | 47.2% | ||
| Q2 24 | 44.7% | 48.2% | ||
| Q1 24 | 40.2% | 49.2% |
営業利益率STEVNT
| Q4 25 | 18.3% | 18.9% | ||
| Q3 25 | 18.2% | 18.9% | ||
| Q2 25 | 17.7% | 17.6% | ||
| Q1 25 | 14.6% | 17.6% | ||
| Q4 24 | 17.9% | 19.2% | ||
| Q3 24 | 16.5% | 17.5% | ||
| Q2 24 | 14.5% | 16.4% | ||
| Q1 24 | 22.0% | 18.8% |
純利益率STEVNT
| Q4 25 | 12.9% | 15.3% | ||
| Q3 25 | 13.1% | 13.7% | ||
| Q2 25 | 12.8% | 11.9% | ||
| Q1 25 | 9.8% | 11.9% | ||
| Q4 24 | 12.7% | 15.9% | ||
| Q3 24 | 11.3% | 12.2% | ||
| Q2 24 | 11.4% | 10.1% | ||
| Q1 24 | -0.1% | 18.1% |
EPS（希薄化後）STEVNT
| Q4 25 | $1.96 | $0.85 | ||
| Q3 25 | $1.94 | $0.70 | ||
| Q2 25 | $1.79 | $0.62 | ||
| Q1 25 | $1.48 | $0.59 | ||
| Q4 24 | $1.75 | $0.82 | ||
| Q3 24 | $1.51 | $0.60 | ||
| Q2 24 | $1.46 | $0.45 | ||
| Q1 24 | $-0.02 | $0.88 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $423.7M | $492.2M |
| 総負債低いほど良い | $1.9B | — |
| 株主資本純資産 | $7.2B | $1.2B |
| 総資産 | $10.6B | $4.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.27× | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資STEVNT
| Q4 25 | $423.7M | $492.2M | ||
| Q3 25 | $319.2M | $433.8M | ||
| Q2 25 | $279.7M | $364.2M | ||
| Q1 25 | $171.7M | $333.6M | ||
| Q4 24 | $155.2M | $356.4M | ||
| Q3 24 | $172.2M | $330.9M | ||
| Q2 24 | $198.3M | $331.3M | ||
| Q1 24 | $207.0M | $406.0M |
総負債STEVNT
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $3.1B | — |
株主資本STEVNT
| Q4 25 | $7.2B | $1.2B | ||
| Q3 25 | $7.0B | $1.2B | ||
| Q2 25 | $7.0B | $1.2B | ||
| Q1 25 | $6.6B | $1.1B | ||
| Q4 24 | $6.4B | $1.1B | ||
| Q3 24 | $6.6B | $1.0B | ||
| Q2 24 | $6.4B | $1.0B | ||
| Q1 24 | $6.3B | $984.9M |
総資産STEVNT
| Q4 25 | $10.6B | $4.4B | ||
| Q3 25 | $10.4B | $4.4B | ||
| Q2 25 | $10.4B | $4.4B | ||
| Q1 25 | $10.1B | $4.3B | ||
| Q4 24 | $10.0B | $4.3B | ||
| Q3 24 | $10.2B | $4.3B | ||
| Q2 24 | $10.1B | $4.2B | ||
| Q1 24 | $11.1B | $4.3B |
負債/資本比率STEVNT
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.50× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $298.2M | $190.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $199.5M | $174.8M |
| FCFマージンFCF / 売上 | 13.3% | 21.6% |
| 設備投資強度設備投資 / 売上 | 6.6% | 1.9% |
| キャッシュ転換率営業CF / 純利益 | 1.55× | 1.54× |
| 直近12ヶ月FCF直近4四半期 | $917.1M | $441.1M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローSTEVNT
| Q4 25 | $298.2M | $190.1M | ||
| Q3 25 | $287.8M | $110.5M | ||
| Q2 25 | $420.0M | $100.0M | ||
| Q1 25 | $260.8M | $110.4M | ||
| Q4 24 | $332.8M | $168.1M | ||
| Q3 24 | $250.7M | $121.8M | ||
| Q2 24 | $303.7M | $46.1M | ||
| Q1 24 | $254.8M | $91.5M |
フリーキャッシュフローSTEVNT
| Q4 25 | $199.5M | $174.8M | ||
| Q3 25 | $201.3M | $90.3M | ||
| Q2 25 | $326.4M | $83.3M | ||
| Q1 25 | $189.9M | $92.7M | ||
| Q4 24 | $243.6M | $148.0M | ||
| Q3 24 | $148.8M | $103.2M | ||
| Q2 24 | $195.7M | $22.3M | ||
| Q1 24 | $163.3M | $71.3M |
FCFマージンSTEVNT
| Q4 25 | 13.3% | 21.6% | ||
| Q3 25 | 13.8% | 12.0% | ||
| Q2 25 | 23.5% | 10.8% | ||
| Q1 25 | 12.8% | 12.5% | ||
| Q4 24 | 17.8% | 19.1% | ||
| Q3 24 | 11.2% | 13.8% | ||
| Q2 24 | 15.3% | 3.2% | ||
| Q1 24 | 14.6% | 9.4% |
設備投資強度STEVNT
| Q4 25 | 6.6% | 1.9% | ||
| Q3 25 | 5.9% | 2.7% | ||
| Q2 25 | 6.7% | 2.2% | ||
| Q1 25 | 4.8% | 2.4% | ||
| Q4 24 | 6.5% | 2.6% | ||
| Q3 24 | 7.7% | 2.5% | ||
| Q2 24 | 8.4% | 3.4% | ||
| Q1 24 | 8.2% | 2.7% |
キャッシュ転換率STEVNT
| Q4 25 | 1.55× | 1.54× | ||
| Q3 25 | 1.50× | 1.07× | ||
| Q2 25 | 2.37× | 1.09× | ||
| Q1 25 | 1.79× | 1.26× | ||
| Q4 24 | 1.92× | 1.36× | ||
| Q3 24 | 1.67× | 1.33× | ||
| Q2 24 | 2.09× | 0.66× | ||
| Q1 24 | — | 0.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
VNT
| Environmental Fueling Solutions Segment | $387.5M | 48% |
| Services | $191.0M | 24% |
| Repair Solutions Segment | $144.5M | 18% |
| Other | $85.5M | 11% |
